Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PIN2 (TERF1) interacting telomerase inhibitor 1 (PINX1) is a nuclear protein that plays a crucial role in the negative regulation of telomerase activity and telomere length maintenance, contributing directly to chromosome stability and acting as a haploinsufficient tumor suppressor[1][2][4][6]. PINX1 binds to the telomerase catalytic subunit TERT and telomerase RNA component (hTR), thereby inhibiting the addition of telomeric repeats and preventing abnormal telomere elongation—a process frequently dysregulated in cancer[4][6]. Loss or reduction of PINX1 leads to increased telomerase activity, telomere lengthening, and chromosomal instability, which are hallmarks of many human cancers[4][6]. Conversely, overexpression of PINX1 can induce cellular crisis and enhance sensitivity to chemotherapeutic agents[4]. PINX1 is being explored both as a biomarker for cancer prognosis and a potential novel therapeutic target, mainly via modulation of telomerase and telomere dynamics[4][6].
- Inhibition of telomerase enzymatic activity (by direct interaction with TERT/hTR complex at telomeres) - Tumor suppressor function via restoration of normal telomere length and chromosomal stability - Sensitization of cancer cells to DNA-damaging agents/chemotherapeutics (by promoting crisis/cell death due to telomere dysfunction)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PIN2 (TERF1) interacting telomerase inhibitor 1 (PINX1).